MVIS vs TECH · rev $4.7M vs P/E 65, rev $1.22B
Microvision Inc (MVIS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Microvision Inc (MVIS) is a scientific & technical instruments company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MVIS revenue for 2024-12-31 was $4.7M. Net income was -$96.9M. Revenue was down 35.3% from 2023-12-31 to 2024-12-31. MVIS currently screens at market cap $200.4M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MVIS currently screens at market cap $200.4M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MVIS and TECH stock pages for the full models.
Not investment advice.